Rapport Therapeutics, Inc. (RAPP) stock
RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.76−1.06 (-4.27%)
Close on Nov 17, 2026Market cap $1.14BP/E –Yield –
Rapport Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Rapport Therapeutics's price to book ratio was 3.1× on Nov 11, 2026, against 2.8× a year earlier. Over the last 2 years it ranged from 1.1× to 5.5×, with a median of 2.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.1× | +0.2 |
| 2025 | Dec 31, 2025 | 2.8× | +0.8 |
| 2024 | Dec 31, 2024 | 2.0× | – |
See a number that looks wrong?